
FDA Proposes, Then Withdraws Study About Kratom and Psychedelics
In a surprising turn of events, the U.S. Food and Drug Administration (FDA) recently withdrew its notice of a proposed study on kratom and psychedelics.
Kratom, CBD, and kava in the news